Single-Nucleotide Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis of Early Onset
- 1 January 2004
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (1) , 209-215
- https://doi.org/10.1046/j.0022-202x.2003.22107.x
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Assignment of Vascular Endothelial Growth Factor (VEGF) and Placenta Growth Factor (PlGF) Genes to Human Chromosome 6p12–p21 and 14q24–q31 Regions, RespectivelyGenomics, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Vascular endothelial growth factor and its receptorsProgress in Growth Factor Research, 1994
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cellsBiochemical and Biophysical Research Communications, 1991
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgarisJournal of the American Academy of Dermatology, 1985